Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SMT NK

Next Previous
Search
Drug Profile

SMT NK

Alternative Names: Natural killer cell therapy - SMT bio; NK Cell therapy - SMT bio; SMT-01; SMT-NK; SMT-NK Inj

Latest Information Update: 18 Feb 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SMT bio
  • Class Antineoplastics; Immunotherapies; Natural killer cell therapies
  • Mechanism of Action Natural killer cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Biliary cancer
  • Phase I Neuroendocrine tumours

Most Recent Events

  • 02 Feb 2024 Phase-I clinical trials in Neuroendocrine tumours (Parenteral), prior to February 2024 (SMT bio pipeline, February 2024)
  • 02 Jun 2023 Efficacy and safety data from a phase- II/III trial in Biliary cancer presented at the 59th Annual Meeting of the American Society of Clinical Oncology (ASCO-2023)
  • 02 Jun 2023 Efficacy and safety data from a phase-I/II trial in Biliary cancer presented at the 59th Annual Meeting of the American Society of Clinical Oncology (ASCO-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top